By using cutting-edge equipment to perform clinical trials, Maulana Azad Medical College (MAMC) and Lok Nayak Jai Prakash Hospital (LNJP) in New Delhi are stepping into the robotic surgery space and providing patients with free procedures. Using the new robotic technology, MAMC’s chief of surgery and certified robotic surgeon Dr. Pawanindra Lal successfully completed six gallbladder stone removal procedures. The patients were discharged the next day without experiencing any substantial pain thanks to the procedures that took place over the course of the previous three days, which was a significant milestone in the hospital’s adoption of state-of-the-art medical equipment.
The purpose of the ongoing clinical trial is to assess how well robotic surgery instruments perform in a range of operations. These include bariatric, cancer, and hernia surgeries in addition to gallbladder stone procedures. The trial is being undertaken in two phases: the first, known as the “pivotal trial,” will see 20 procedures performed at Max Hospital in Vaishali; the other 20 surgeries will be performed by MAMC and Max Hospital jointly. The outcomes of these studies will aid in determining if the robotic surgery apparatus is appropriate for a broader spectrum of medical operations.
The six-week trial period is essential for evaluating the system’s functionality and making sure it can be applied to various surgical procedures. The trials will also aid in determining how effectively the treatments and equipment work with the hospitals’ current setup and how helpful they are for patients in terms of recovery time and overall efficacy.
Comparing robotic surgery to conventional surgical techniques, there are numerous benefits. It enables more accurate motions, fewer incisions, and quicker patient recoveries. Surgeons are better able to control and accurately execute difficult procedures, which lowers the possibility of problems and enhances patient outcomes. By concentrating on robotic surgery, MAMC hopes to provide these advantages to a larger group of patients, particularly those who might not otherwise be able to afford cutting-edge surgical methods.
Following the completion of the clinical trials, MAMC intends to purchase robotic surgery apparatus for itself. This will make it possible for the hospital to go on providing robotic surgery, guaranteeing that patients will always have access to this cutting-edge equipment. By investing in new technology and offering free surgeries during the trial period, MAMC is exhibiting its dedication to enhancing patient outcomes and accessibility to healthcare.
SOURCE :
TIMES OF INDIA
